BioCentury
ARTICLE | Company News

Trinity files Remune NDA in Thailand

July 30, 2001 7:00 AM UTC

Trinity Medical Group (TMGU) filed an NDA with health authorities in Thailand for its HIV-1 immunogen product, Remune, as a primary treatment for HIV infection. TMGU has a license from Immune Response...